Axcelis

ACLS

Market cap $2.64B

BEVERLY, Mass., Feb. 23, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: The Susquehanna Financial Group Fifteenth Annual Technology Conference, taking place at the Lotte New York Palace Hotel on February 26th and virtually on February 27th, 2026.

ACLS, CE and CMCSA have been added to the Zacks Rank #5 (Strong Sell) List on February 23, 2026.

Axcelis Technologies, Inc. (ACLS) Q4 2025 Earnings Call Transcript

Axcelis Technologies (ACLS) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.54 per share a year ago.

Q4 Highlights: Revenue of $238 million GAAP Gross Margin of 47.0%, and Non-GAAP Gross Margin of 47.3% GAAP Operating Margin of 15.2% and Non-GAAP Operating Margin of 21.1% GAAP Diluted Earnings Per Share of $1.10, and Non-GAAP Diluted Earnings Per Share of $1.49 BEVERLY, Mass., Feb. 17, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2025.

BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) ("Axcelis") today announced that its stockholders have voted to approve all proposals related to the Company's pending merger (the "Merger") with Veeco Instruments Inc. (Nasdaq: VECO) at its Special Meeting of Stockholders ("Special Meeting").

In the latest trading session, Axcelis Technologies (ACLS) closed at $82.76, marking a -1.91% move from the previous day.

Highlighting New Technologies That Advance Intelligent Semiconductor Manufacturing Solutions BEVERLY, Mass., Feb. 4, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Purion™ platform of ion implanters at SEMICON Korea 2026.

BEVERLY, Mass., Feb. 4, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today introduced the Purion H6™ high current ion implanter—engineered to meet the demands of next-generation semiconductor devices with unmatched purity, precision and productivity.

Axcelis Technologies (ACLS) closed at $92.2 in the latest trading session, marking a +1.06% move from the prior day.